Gut Microbial Injury and Recovery After Allogeneic HCT
Kaundal S, Patil AN, Khatri P, et al. Early Gut Microbiome Metabolites and Diversity Predict Graft-Versus-Host Disease-Free Survival After Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 2026; (doi: 10.1016/j.jtct.2026.09.012).
Building on the hypothesis that a disrupted gut microbiome contributes to graft-versus-host disease (GVHD), researchers investigated the effect of gut microbial metabolic injury and impaired recovery soon after allogeneic hematopoietic cell transplantation (allo-HCT). The longitudinal, observational study included 62 patients, whose pre- and post-transplant stool samples facilitated analysis of the fecal short-chain fatty acids (SCFAs) butyrate, propionate, and acetate. The researchers theorized, and subsequently demonstrated, that depletion of those metabolites at week 2 and impaired recovery of microbial diversity by week 4 were associated with poor long-term GVHD-free survival (GFS), measured as survival absent grade II-IV acute GVHD, moderate–to-severe chronic GVHD, or death. During 2 years of follow-up, 43 participants (69%) missed the primary outcome of GFS, which improved in patients with higher concentrations of all three SCFAs and strong recovery of microbiome diversity. The findings suggest resilience to transplant-related injury, rather than microbial composition at baseline, informs downstream outcomes and that there is an opportunity early after HCT to introduce microbiome-targeted interventions to support favorable results.